[{"Assets_0_Q1_USD":345228000.0,"CommonStockSharesOutstanding_0_Q1_shares":50887102.0,"EarningsPerShareBasic_1_Q1_USD":-0.45,"EarningsPerShareDiluted_1_Q1_USD":-0.45,"NetIncomeLoss_1_Q1_USD":-23064000.0,"StockholdersEquity_0_Q1_USD":57780000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":50886.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":50886.0,"Ticker":"SRNE","CIK":"850261","name":"SORRENTO THERAPEUTICS, INC.","OfficialName":"Sorrento Therapeutics Inc.  Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"636044097.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20170515"}]